Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share News (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades64
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Company
Research
SYNC Company
Timeline
Syncona Information
Share Price Information for Syncona (SYNC)
Share Price is delayed by 15 minutes
Get Live Data
95.40
-0.80 (-0.83%)
Bid:
96.00
Ask:
96.80
Spread:
0.80 (0.833%)
Market Cap:
£580.22m
Last checked at -
Last checked at 
Intraday Syncona Share Chart
Syncona News
19 Apr 2021
Syncona's Gyroscope Therapeutics files for potential US IPO
Syncona's Gyroscope Therapeutics files for potential US IPO
6 Apr 2021
IN BRIEF: Syncona director and CIO sell GBP1.6 million in shares
IN BRIEF: Syncona director and CIO sell GBP1.6 million in shares
1 Apr 2021
TRADING UPDATES: 4D Pharma loss widens on rise in administrative costs
TRADING UPDATES: 4D Pharma loss widens on rise in administrative costs
31 Mar 2021
Syncona says Achilles stake leaps to GBP145 million value after IPO
Syncona says Achilles stake leaps to GBP145 million value after IPO
31 Mar 2021
Achilles Therapeutics prices IPO at $175m as Syncona keeps 27% stake
(Sharecast News) - Syncona portfolio biopharma company Achilles Therapeutics said its US initial public offering (IPO) will raise $175.5m (£127.8...
30 Mar 2021
DIRECTOR DEALINGS: Gym Group directors sell GBP1.8 million in shares
DIRECTOR DEALINGS: Gym Group directors sell GBP1.8 million in shares
26 Mar 2021
Syncona invests USD42 million into Gyroscope to have 54% stake
Syncona invests USD42 million into Gyroscope to have 54% stake
26 Mar 2021
Syncona invests £31m in Gyroscope
(Sharecast News) - Syncona has invested $42.3m (£31m) in Gyroscope Therapeutics as part of a $148m financing by the retinal gene therapy company.
Follow the stocks
